Company Profiles

driven by the PitchBook Platform

Mimetogen Pharmaceuticals

Mimetogen Pharmaceuticals
2005 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$800k LATEST DEAL AMOUNT
$1.65M TOTAL AMOUNT RAISED
Description

Developer of small molecule drugs for eye treatment. The company is a biotechnology company focused on treatment of dry eye, glaucoma, keratoconus and retinitis pigmentosa.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
1000 de La Gauchetiere Street West
Suite 900
Montreal, Quebec H3B 5H4
Canada

+1 (514) 667-5869
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mimetogen Pharmaceuticals’s full profile, request a free trial.

Mimetogen Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 18-Jul-2013 $800k $1.65M Completed Startup
3. Later Stage VC (Series B) 25-Feb-2011 00000 Completed Startup
2. Early Stage VC (Series A) 07-Oct-2009 $848k Completed Startup
1. Seed Round 31-Oct-2005 $848k $848k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Mimetogen Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MSBi Valorisation Venture Capital Minority 000 0000 000000 0
Medwell Capital Other Minority 000 0000 000000 0
Schooner Capital PE/Buyout Minority 000 0000 000000 0
VIMAC Ventures Venture Capital Minority 000 0000 000000 0
iNovia Capital Venture Capital Minority 000 0000 000000 0

Mimetogen Pharmaceuticals Executive Team (8)

Name Title Board
Seat
Contact
Info
Garth Cumberlidge Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Francois Mongrain Vice President of Finance & Chief Financial Officer
Karen Meerovitch Ph.D Senior Director of Clinical Development
Stephen Pflugfelder MD Advisor
Edward Holland MD Advisor
You’re viewing 5 of 8 executives. Get the full list »

Mimetogen Pharmaceuticals Board Members (6)

Name Representing Role Since Contact
Info
C├ędric Bisson MD Self Board Member 000 0000
Garth Cumberlidge Ph.D Mimetogen Pharmaceuticals Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Martin Wax MD Self Chairman 000 0000
Sena Biswas Ph.D VIMAC Ventures Board Member 000 0000

2 Former Board Members

You’re viewing 4 of 6 board members. Get the full list »